Physician profile
Willis E Martin
NPI 1902042278
$1,744.25
in general payments reported to CMS, 2019-2025
19 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $856 · 2020: $246 · 2021: $111 · 2022: $349 · 2023: $57.23 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $182.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $909.31 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $217.65 | 2019-2021 | |
| Arcutis Biotherapeutics, INC. | $124.99 | 2025 | Zoryve |
| Amgen INC. | $75.15 | 2019-2020 | |
| Janssen Biotech, INC. | $54.95 | 2022 | |
| Lilly USA, LLC | $53.04 | 2019-2022 | |
| Pfizer INC. | $52.45 | 2019-2022 | |
| Almirall LLC | $42.67 | 2019 | |
| Organogenesis INC. | $34.46 | 2021 | |
| Merz North America, INC. | $29.96 | 2019 | |
| Genzyme Corporation | $21.35 | 2022 | |
| Celgene Corporation | $20.49 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $18.43 | 2023 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $18.14 | 2021 | |
| Allergan, INC. | $15.56 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vyne Pharmaceuticals INC. | $14.85 | 2020 | |
| Pierre Fabre Pharmaceuticals, INC. | $14.46 | 2019 | |
| Mayne Pharma Commercial LLC | $13.54 | 2019 | |
| Merck Sharp & Dohme LLC | $12.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Willis Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.